Exodus Point Capital Management, LP Arcus Biosciences, Inc. Transaction History

Exodus Point Capital Management, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$14.59 - $18.48 $860,095 - $1.09 Million	58,951 New	58,951 $898,000
Q3 2023 Nov 09, 2023	SELL	$17.62 - $23.54 $3.23 Million - $4.32 Million	-183,330 Reduced 42.0%	253,140 $4.54 Million
Q2 2023 Aug 10, 2023	BUY	$16.97 - $22.03 $157,108 - $203,953	9,258 Added 2.17%	436,470 $8.87 Million
Q1 2023 May 11, 2023	BUY	$15.96 - $23.15 $6.28 Million - $9.1 Million	393,201 Added 1156.1%	427,212 $7.79 Million
Q4 2022 Feb 13, 2023	BUY	$19.7 - $35.71 $218,985 - $396,952	11,116 Added 48.55%	34,011 $703,000
Q3 2022 Nov 10, 2022	SELL	$23.23 - $30.07 $1.08 Million - $1.4 Million	-46,492 Reduced 67.0%	22,895 $599,000
Q2 2022 Aug 19, 2022	BUY	$17.23 - $37.73 $682,308 - $1.49 Million	39,600 Added 132.94%	69,387 $1.76 Million
Q1 2022 May 13, 2022	BUY	$28.92 - $41.83 $861,440 - $1.25 Million	29,787 New	29,787 $940,000
Q1 2021 May 17, 2021	SELL	$26.16 - $41.39 $219,482 - $347,262	-8,390 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $142,630 - $271,500	8,390 New	8,390 $218,000
Q3 2020 Nov 16, 2020	SELL	$17.14 - $25.47 $714,703 - $1.06 Million	-41,698 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $582,521 - $1.52 Million	41,698 New	41,698 $1.03 Million
Q3 2019 Nov 14, 2019	SELL	$6.44 - $10.18 $82,328 - $130,141	-12,784 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$7.29 - $13.38 $93,195 - $171,049	12,784 New	12,784 $102,000

198

51.4M

236K

141K

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $864M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.